BRAF Kinase Inhibitors Market, Global Outlook and Forecast 2022-2028

March 2022 | 74 pages | ID: B9DDD047136FEN
Market Monitor Global

Abstracts

BRAF kinase inhibitors are generally used as targeted therapy drugs for the treatment of carcinomas such as RCC, NSCLC, and melanomas caused by mutations of the BRAF gene.

This report contains market size and forecasts of BRAF Kinase Inhibitors in global, including the following market information:

Global BRAF Kinase Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global BRAF Kinase Inhibitors Market Sales, 2017-2022, 2023-2028, (K Liter)

Global top five BRAF Kinase Inhibitors companies in 2021 (%)

The global BRAF Kinase Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Dabrafenib Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of BRAF Kinase Inhibitors include Array BioPharma Inc., Bayer AG, F. Hoffmann-La Roche Ltd. and Novartis AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the BRAF Kinase Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global BRAF Kinase Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Liter)

Global BRAF Kinase Inhibitors Market Segment Percentages, by Type, 2021 (%)

• Dabrafenib
• Sorafenib
• Vemurafenib
• Encorafenib

Global BRAF Kinase Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Liter)

Global BRAF Kinase Inhibitors Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Medical Research Institute
• Clinic
• Other

Global BRAF Kinase Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Liter)

Global BRAF Kinase Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies BRAF Kinase Inhibitors revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies BRAF Kinase Inhibitors revenues share in global market, 2021 (%)

Key companies BRAF Kinase Inhibitors sales in global market, 2017-2022 (Estimated), (K Liter)

Key companies BRAF Kinase Inhibitors sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Array BioPharma Inc.
• Bayer AG
• F. Hoffmann-La Roche Ltd.
• Novartis AG

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 BRAF Kinase Inhibitors Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global BRAF Kinase Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BRAF KINASE INHIBITORS OVERALL MARKET SIZE

2.1 Global BRAF Kinase Inhibitors Market Size: 2021 VS 2028
2.2 Global BRAF Kinase Inhibitors Revenue, Prospects & Forecasts: 2017-2028
2.3 Global BRAF Kinase Inhibitors Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top BRAF Kinase Inhibitors Players in Global Market
3.2 Top Global BRAF Kinase Inhibitors Companies Ranked by Revenue
3.3 Global BRAF Kinase Inhibitors Revenue by Companies
3.4 Global BRAF Kinase Inhibitors Sales by Companies
3.5 Global BRAF Kinase Inhibitors Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 BRAF Kinase Inhibitors Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers BRAF Kinase Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 BRAF Kinase Inhibitors Players in Global Market
  3.8.1 List of Global Tier 1 BRAF Kinase Inhibitors Companies
  3.8.2 List of Global Tier 2 and Tier 3 BRAF Kinase Inhibitors Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global BRAF Kinase Inhibitors Market Size Markets, 2021 & 2028
  4.1.2 Dabrafenib
  4.1.3 Sorafenib
  4.1.4 Vemurafenib
  4.1.5 Encorafenib
4.2 By Type - Global BRAF Kinase Inhibitors Revenue & Forecasts
  4.2.1 By Type - Global BRAF Kinase Inhibitors Revenue, 2017-2022
  4.2.2 By Type - Global BRAF Kinase Inhibitors Revenue, 2023-2028
  4.2.3 By Type - Global BRAF Kinase Inhibitors Revenue Market Share, 2017-2028
4.3 By Type - Global BRAF Kinase Inhibitors Sales & Forecasts
  4.3.1 By Type - Global BRAF Kinase Inhibitors Sales, 2017-2022
  4.3.2 By Type - Global BRAF Kinase Inhibitors Sales, 2023-2028
  4.3.3 By Type - Global BRAF Kinase Inhibitors Sales Market Share, 2017-2028
4.4 By Type - Global BRAF Kinase Inhibitors Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global BRAF Kinase Inhibitors Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Medical Research Institute
  5.1.4 Clinic
  5.1.5 Other
5.2 By Application - Global BRAF Kinase Inhibitors Revenue & Forecasts
  5.2.1 By Application - Global BRAF Kinase Inhibitors Revenue, 2017-2022
  5.2.2 By Application - Global BRAF Kinase Inhibitors Revenue, 2023-2028
  5.2.3 By Application - Global BRAF Kinase Inhibitors Revenue Market Share, 2017-2028
5.3 By Application - Global BRAF Kinase Inhibitors Sales & Forecasts
  5.3.1 By Application - Global BRAF Kinase Inhibitors Sales, 2017-2022
  5.3.2 By Application - Global BRAF Kinase Inhibitors Sales, 2023-2028
  5.3.3 By Application - Global BRAF Kinase Inhibitors Sales Market Share, 2017-2028
5.4 By Application - Global BRAF Kinase Inhibitors Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global BRAF Kinase Inhibitors Market Size, 2021 & 2028
6.2 By Region - Global BRAF Kinase Inhibitors Revenue & Forecasts
  6.2.1 By Region - Global BRAF Kinase Inhibitors Revenue, 2017-2022
  6.2.2 By Region - Global BRAF Kinase Inhibitors Revenue, 2023-2028
  6.2.3 By Region - Global BRAF Kinase Inhibitors Revenue Market Share, 2017-2028
6.3 By Region - Global BRAF Kinase Inhibitors Sales & Forecasts
  6.3.1 By Region - Global BRAF Kinase Inhibitors Sales, 2017-2022
  6.3.2 By Region - Global BRAF Kinase Inhibitors Sales, 2023-2028
  6.3.3 By Region - Global BRAF Kinase Inhibitors Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America BRAF Kinase Inhibitors Revenue, 2017-2028
  6.4.2 By Country - North America BRAF Kinase Inhibitors Sales, 2017-2028
  6.4.3 US BRAF Kinase Inhibitors Market Size, 2017-2028
  6.4.4 Canada BRAF Kinase Inhibitors Market Size, 2017-2028
  6.4.5 Mexico BRAF Kinase Inhibitors Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe BRAF Kinase Inhibitors Revenue, 2017-2028
  6.5.2 By Country - Europe BRAF Kinase Inhibitors Sales, 2017-2028
  6.5.3 Germany BRAF Kinase Inhibitors Market Size, 2017-2028
  6.5.4 France BRAF Kinase Inhibitors Market Size, 2017-2028
  6.5.5 U.K. BRAF Kinase Inhibitors Market Size, 2017-2028
  6.5.6 Italy BRAF Kinase Inhibitors Market Size, 2017-2028
  6.5.7 Russia BRAF Kinase Inhibitors Market Size, 2017-2028
  6.5.8 Nordic Countries BRAF Kinase Inhibitors Market Size, 2017-2028
  6.5.9 Benelux BRAF Kinase Inhibitors Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia BRAF Kinase Inhibitors Revenue, 2017-2028
  6.6.2 By Region - Asia BRAF Kinase Inhibitors Sales, 2017-2028
  6.6.3 China BRAF Kinase Inhibitors Market Size, 2017-2028
  6.6.4 Japan BRAF Kinase Inhibitors Market Size, 2017-2028
  6.6.5 South Korea BRAF Kinase Inhibitors Market Size, 2017-2028
  6.6.6 Southeast Asia BRAF Kinase Inhibitors Market Size, 2017-2028
  6.6.7 India BRAF Kinase Inhibitors Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America BRAF Kinase Inhibitors Revenue, 2017-2028
  6.7.2 By Country - South America BRAF Kinase Inhibitors Sales, 2017-2028
  6.7.3 Brazil BRAF Kinase Inhibitors Market Size, 2017-2028
  6.7.4 Argentina BRAF Kinase Inhibitors Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa BRAF Kinase Inhibitors Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa BRAF Kinase Inhibitors Sales, 2017-2028
  6.8.3 Turkey BRAF Kinase Inhibitors Market Size, 2017-2028
  6.8.4 Israel BRAF Kinase Inhibitors Market Size, 2017-2028
  6.8.5 Saudi Arabia BRAF Kinase Inhibitors Market Size, 2017-2028
  6.8.6 UAE BRAF Kinase Inhibitors Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Array BioPharma Inc.
  7.1.1 Array BioPharma Inc. Corporate Summary
  7.1.2 Array BioPharma Inc. Business Overview
  7.1.3 Array BioPharma Inc. BRAF Kinase Inhibitors Major Product Offerings
  7.1.4 Array BioPharma Inc. BRAF Kinase Inhibitors Sales and Revenue in Global (2017-2022)
  7.1.5 Array BioPharma Inc. Key News
7.2 Bayer AG
  7.2.1 Bayer AG Corporate Summary
  7.2.2 Bayer AG Business Overview
  7.2.3 Bayer AG BRAF Kinase Inhibitors Major Product Offerings
  7.2.4 Bayer AG BRAF Kinase Inhibitors Sales and Revenue in Global (2017-2022)
  7.2.5 Bayer AG Key News
7.3 F. Hoffmann-La Roche Ltd.
  7.3.1 F. Hoffmann-La Roche Ltd. Corporate Summary
  7.3.2 F. Hoffmann-La Roche Ltd. Business Overview
  7.3.3 F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Major Product Offerings
  7.3.4 F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Sales and Revenue in Global (2017-2022)
  7.3.5 F. Hoffmann-La Roche Ltd. Key News
7.4 Novartis AG
  7.4.1 Novartis AG Corporate Summary
  7.4.2 Novartis AG Business Overview
  7.4.3 Novartis AG BRAF Kinase Inhibitors Major Product Offerings
  7.4.4 Novartis AG BRAF Kinase Inhibitors Sales and Revenue in Global (2017-2022)
  7.4.5 Novartis AG Key News

8 GLOBAL BRAF KINASE INHIBITORS PRODUCTION CAPACITY, ANALYSIS

8.1 Global BRAF Kinase Inhibitors Production Capacity, 2017-2028
8.2 BRAF Kinase Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global BRAF Kinase Inhibitors Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 BRAF KINASE INHIBITORS SUPPLY CHAIN ANALYSIS

10.1 BRAF Kinase Inhibitors Industry Value Chain
10.2 BRAF Kinase Inhibitors Upstream Market
10.3 BRAF Kinase Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 BRAF Kinase Inhibitors Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of BRAF Kinase Inhibitors in Global Market
Table 2. Top BRAF Kinase Inhibitors Players in Global Market, Ranking by Revenue (2021)
Table 3. Global BRAF Kinase Inhibitors Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global BRAF Kinase Inhibitors Revenue Share by Companies, 2017-2022
Table 5. Global BRAF Kinase Inhibitors Sales by Companies, (K Liter), 2017-2022
Table 6. Global BRAF Kinase Inhibitors Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers BRAF Kinase Inhibitors Price (2017-2022) & (USD/Liter)
Table 8. Global Manufacturers BRAF Kinase Inhibitors Product Type
Table 9. List of Global Tier 1 BRAF Kinase Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 BRAF Kinase Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global BRAF Kinase Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global BRAF Kinase Inhibitors Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global BRAF Kinase Inhibitors Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global BRAF Kinase Inhibitors Sales (K Liter), 2017-2022
Table 15. By Type - Global BRAF Kinase Inhibitors Sales (K Liter), 2023-2028
Table 16. By Application – Global BRAF Kinase Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global BRAF Kinase Inhibitors Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global BRAF Kinase Inhibitors Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global BRAF Kinase Inhibitors Sales (K Liter), 2017-2022
Table 20. By Application - Global BRAF Kinase Inhibitors Sales (K Liter), 2023-2028
Table 21. By Region – Global BRAF Kinase Inhibitors Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global BRAF Kinase Inhibitors Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global BRAF Kinase Inhibitors Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global BRAF Kinase Inhibitors Sales (K Liter), 2017-2022
Table 25. By Region - Global BRAF Kinase Inhibitors Sales (K Liter), 2023-2028
Table 26. By Country - North America BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America BRAF Kinase Inhibitors Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America BRAF Kinase Inhibitors Sales, (K Liter), 2017-2022
Table 29. By Country - North America BRAF Kinase Inhibitors Sales, (K Liter), 2023-2028
Table 30. By Country - Europe BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe BRAF Kinase Inhibitors Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe BRAF Kinase Inhibitors Sales, (K Liter), 2017-2022
Table 33. By Country - Europe BRAF Kinase Inhibitors Sales, (K Liter), 2023-2028
Table 34. By Region - Asia BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia BRAF Kinase Inhibitors Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia BRAF Kinase Inhibitors Sales, (K Liter), 2017-2022
Table 37. By Region - Asia BRAF Kinase Inhibitors Sales, (K Liter), 2023-2028
Table 38. By Country - South America BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America BRAF Kinase Inhibitors Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America BRAF Kinase Inhibitors Sales, (K Liter), 2017-2022
Table 41. By Country - South America BRAF Kinase Inhibitors Sales, (K Liter), 2023-2028
Table 42. By Country - Middle East & Africa BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa BRAF Kinase Inhibitors Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa BRAF Kinase Inhibitors Sales, (K Liter), 2017-2022
Table 45. By Country - Middle East & Africa BRAF Kinase Inhibitors Sales, (K Liter), 2023-2028
Table 46. Array BioPharma Inc. Corporate Summary
Table 47. Array BioPharma Inc. BRAF Kinase Inhibitors Product Offerings
Table 48. Array BioPharma Inc. BRAF Kinase Inhibitors Sales (K Liter), Revenue (US$, Mn) and Average Price (USD/Liter) (2017-2022)
Table 49. Bayer AG Corporate Summary
Table 50. Bayer AG BRAF Kinase Inhibitors Product Offerings
Table 51. Bayer AG BRAF Kinase Inhibitors Sales (K Liter), Revenue (US$, Mn) and Average Price (USD/Liter) (2017-2022)
Table 52. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 53. F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Product Offerings
Table 54. F. Hoffmann-La Roche Ltd. BRAF Kinase Inhibitors Sales (K Liter), Revenue (US$, Mn) and Average Price (USD/Liter) (2017-2022)
Table 55. Novartis AG Corporate Summary
Table 56. Novartis AG BRAF Kinase Inhibitors Product Offerings
Table 57. Novartis AG BRAF Kinase Inhibitors Sales (K Liter), Revenue (US$, Mn) and Average Price (USD/Liter) (2017-2022)
Table 58. BRAF Kinase Inhibitors Production Capacity (K Liter) of Key Manufacturers in Global Market, 2020-2022 (K Liter)
Table 59. Global BRAF Kinase Inhibitors Capacity Market Share of Key Manufacturers, 2020-2022
Table 60. Global BRAF Kinase Inhibitors Production by Region, 2017-2022 (K Liter)
Table 61. Global BRAF Kinase Inhibitors Production by Region, 2023-2028 (K Liter)
Table 62. BRAF Kinase Inhibitors Market Opportunities & Trends in Global Market
Table 63. BRAF Kinase Inhibitors Market Drivers in Global Market
Table 64. BRAF Kinase Inhibitors Market Restraints in Global Market
Table 65. BRAF Kinase Inhibitors Raw Materials
Table 66. BRAF Kinase Inhibitors Raw Materials Suppliers in Global Market
Table 67. Typical BRAF Kinase Inhibitors Downstream
Table 68. BRAF Kinase Inhibitors Downstream Clients in Global Market
Table 69. BRAF Kinase Inhibitors Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. BRAF Kinase Inhibitors Segment by Type
Figure 2. BRAF Kinase Inhibitors Segment by Application
Figure 3. Global BRAF Kinase Inhibitors Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global BRAF Kinase Inhibitors Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global BRAF Kinase Inhibitors Revenue, 2017-2028 (US$, Mn)
Figure 7. BRAF Kinase Inhibitors Sales in Global Market: 2017-2028 (K Liter)
Figure 8. The Top 3 and 5 Players Market Share by BRAF Kinase Inhibitors Revenue in 2021
Figure 9. By Type - Global BRAF Kinase Inhibitors Sales Market Share, 2017-2028
Figure 10. By Type - Global BRAF Kinase Inhibitors Revenue Market Share, 2017-2028
Figure 11. By Type - Global BRAF Kinase Inhibitors Price (USD/Liter), 2017-2028
Figure 12. By Application - Global BRAF Kinase Inhibitors Sales Market Share, 2017-2028
Figure 13. By Application - Global BRAF Kinase Inhibitors Revenue Market Share, 2017-2028
Figure 14. By Application - Global BRAF Kinase Inhibitors Price (USD/Liter), 2017-2028
Figure 15. By Region - Global BRAF Kinase Inhibitors Sales Market Share, 2017-2028
Figure 16. By Region - Global BRAF Kinase Inhibitors Revenue Market Share, 2017-2028
Figure 17. By Country - North America BRAF Kinase Inhibitors Revenue Market Share, 2017-2028
Figure 18. By Country - North America BRAF Kinase Inhibitors Sales Market Share, 2017-2028
Figure 19. US BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 20. Canada BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe BRAF Kinase Inhibitors Revenue Market Share, 2017-2028
Figure 23. By Country - Europe BRAF Kinase Inhibitors Sales Market Share, 2017-2028
Figure 24. Germany BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 25. France BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 27. Italy BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 28. Russia BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia BRAF Kinase Inhibitors Revenue Market Share, 2017-2028
Figure 32. By Region - Asia BRAF Kinase Inhibitors Sales Market Share, 2017-2028
Figure 33. China BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 34. Japan BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 37. India BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America BRAF Kinase Inhibitors Revenue Market Share, 2017-2028
Figure 39. By Country - South America BRAF Kinase Inhibitors Sales Market Share, 2017-2028
Figure 40. Brazil BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa BRAF Kinase Inhibitors Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa BRAF Kinase Inhibitors Sales Market Share, 2017-2028
Figure 44. Turkey BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 45. Israel BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 47. UAE BRAF Kinase Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 48. Global BRAF Kinase Inhibitors Production Capacity (K Liter), 2017-2028
Figure 49. The Percentage of Production BRAF Kinase Inhibitors by Region, 2021 VS 2028
Figure 50. BRAF Kinase Inhibitors Industry Value Chain
Figure 51. Marketing Channels